Description

5-Bromo-n-(Cyclobutylmethyl)Pyridine-3-Sulfonamide is a high-purity, advanced pharmaceutical intermediate characterized by its sulfonamide and brominated pyridine structure. This compound matters for its critical role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. Pharmaceutical R&D teams and fine chemical manufacturers need this precise intermediate to develop next-generation drug candidates with potential applications in oncology and central nervous system (CNS) disorders.

Application

• Primary building block for the synthesis of novel small molecule drug candidates in pharmaceutical research.
• Key intermediate in the development of kinase inhibitors and other targeted therapies for oncology applications.
• Precursor for creating complex sulfonamide-based compounds with potential biological activity.
• Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Intermediate in the production of specialized fine chemicals and custom synthesis projects for biotechnology firms.
• Research chemical for academic and industrial studies exploring new heterocyclic compound functionalities.

Basic Information

Product Name	5-Bromo-n-(Cyclobutylmethyl)Pyridine-3-Sulfonamide
CAS No.	1250508-64-5
Molecular Formula	C10H13BrN2O2S
Molecular Weight	305.19 g/mol
Synonyms	5-Bromo-N-(cyclobutylmethyl)pyridine-3-sulfonamide; 3-Pyridinesulfonamide, 5-bromo-N-(cyclobutylmethyl)-; 5-Bromo-N-cyclobutylmethylpyridine-3-sulfonamide; 1250508-64-5; 5-Br-N-CBM-PSA; 5-Bromo-3-sulfamoyl-N-(cyclobutylmethyl)pyridine; 5-Bromo-N-(cyclobutylmethyl)-3-pyridinesulfonamide
EINECS	Contact for details

Quality Control

Our 5-Bromo-n-(Cyclobutylmethyl)Pyridine-3-Sulfonamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with full traceability are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic; keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.